Salvage Treatment or Active Clinical Surveillance for Oligometastatic Prostate Cancer: a Randomized Phase II Trial
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Androgen deprivation therapy free survival.
Androgen deprivation therapy free survival will be calculated from randomization until androgen deprivation therapy is started.
From date of randomization until androgen deprivation therapy is started, assessed up to 2 years.
Gert De Meerleer, PhD, MD
Ghent University Hospital
Belgium: Ethics Committee